Market Research Logo

Asia-Pacific Dry Eye Syndrome Market – Industry Trends and Forecast to 2026

Asia-Pacific Dry Eye Syndrome Market – Industry Trends and Forecast to 2026

Short Description

By Product Type (Tear stimulators, Artificial tears, Secretagogue, Others), Dosage Type (Liquid, Semi-solid, Others), Drug Class (Lubricating Agents, Cholinergics, Anti-Inflammatory, Anti-Infectives, Anti-Allergics, Others), Dose( Unit dose, Multi-dose ), Medication Type( Prescription (Rx) Drugs, Over The Counter (OTC) Drugs), Container Type (Unit-Dose Vials, Bottles, Tubes), Packaging Type( Plastic, Aluminium, Glass), Type(Brands, Generics), End Users (Home Healthcare, Hospitals, Clinics, Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), Country (Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific)

Market Definition:
Dry eye is a multifactorial disease of the tears and ocular surface that causes symptoms of disquiet visual disturbance and tears film variability with possible damage to the ocular surface. It is escorted increase in tear film osmolality and ocular surface inflammation which may result in substantial damage of eye. The symptoms of dry eye syndrome includes eye redness, blurred vision and eye fatigue, watery eyes, which is the body's response to the irritation of dry eyes such as stinging burning and scratchy sensation in eyes.

Market Segmentation:
Asia-Pacific dry eye syndrome market is segmented into ten notable segments which are basis of product type, dosage type, drug class, dose, medication type, container type, packaging type, type, end user and distribution channel.
• On the basis of product type, the market is segmented into tear stimulators, artificial tears, secretagogue and others
• On the basis of dosage type, the market is segmented into liquid, semi solid and others
• On the basis of drug class, the market is segmented into anti-inflammatory, lubricating agents, anti-infectives, anti-allergics, cholinergics and others
• On the basis of dose, the market is segmented into multi dose and unit dose
• On the basis of medication type, the market is segmented into prescription (RX) drugs, and over the counter (OTC) drugs
• On the basis of container type, the market is segmented into unit dose vials, bottles, and tubes
• On the basis of packaging type, the market is segmented into plastic, glass, and aluminium
• On the basis of type, the market is segmented into generics and brands
• On the basis of end user, the market is segmented into home healthcare, hospitals, clinics, and others
• On the basis of distribution channel, the market is segmented into hospital pharmacies, retail pharmacies, online pharmacies and others

Market Players
Major players in Asia-Pacific dry eye syndrome market are:
• ALLERGAN
• Bausch & Lomb Incorporated
• Novartis AG
• Johnson & Johnson Services, Inc.
• Prestige Consumer Healthcare, Inc.
• AKORN, INC.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Novaliq GmbH
• Santen Pharmaceutical Co., Ltd.,
• Cardinal Health
• Alembic Pharmaceuticals Limited.
• Cipla Inc.
• Perrigo Company plc
• SENJU PHARMACEUTICAL CO. LTD.
• Horus Pharma
• ROHTO Pharmaceutical Co., Ltd.
• VISUfarma
• Hubrx

The single user license is non-downloadable and non-printable. Global Site license allows these actions.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of Asia-pacific Dry Eye Syndrome Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Asia-pacific Dry Eye Syndrome Market: Geographical Scope
2.3 Years Considered For The Study
2.4 Currency And Pricing
2.5 Dbmr Tripod Data Validation Model
2.6 Primary Interviews With Key Opinion Leaders
2.7 Dbmr Market Position Grid
2.8 Dbmr Vendor Share Analysis
2.9 Multivariate Modeling
2.10 Products Lifeline Curve
2.11 Secondary Sources
2.12 Assumptions
3 Market Overview
3.1 Drivers
3.1.1 Increasing Prevalence Of Dry Eye Diseases
3.1.2 Changing Geographical Trends To Drive The Market
3.1.3 Increasing Awareness About Diagnosis And Treatment Of The Disease
3.1.4 Rising Geriatric Population Across The World
3.1.5 Increase In Lasik Surgery And Usage Of Contact Lenses
3.2 Restraints
3.2.1 Stringent Regulatory Process
3.2.2 Unmet Medical Needs
3.3 Opportunities
3.3.1 Emerging Market Presents Significant Opportunities
3.3.2 Development Of Novel Technologies
3.4 Challenge
3.4.1 Increasing Number Of Players
4 Executive Summary
5 Premium Insights
6 Pipeline Analysis
6.1 Overview
6.2 Marketed Drugs
6.3 Approved/Filed Drugs
6.4 Phase Iii Trial Candidates
6.5 Phase Ii Trial Candidates
6.6 Phase I Trial Candidates
6.7 Others
7 Asia-pacific Dry Eye Syndrome Market, By Product Type
7.1 Overview
7.2 Tear Stimulators
7.2.1 Pilocarpine
7.2.2 Cyclosporine
7.2.3 Lifitegrast
7.3 Artificial Tears
7.3.1 Secretagogue
7.3.2 Others
8 Asia-pacific Dry Eye Syndrome Market, By Dosage Type
8.1 Overview
8.2 Liquid
8.2.1 Solutions
8.2.2 Emulsions
8.2.3 Suspensions
8.3 Semi-solid
8.3.1 Gel
8.3.2 Ointment
8.4 Others
9 Asia-pacific Dry Eye Syndrome Market, By Drug Class
9.1 Overview
9.2 Anti-inflammatory
9.3 Lubricating Agent
9.4 Anti-infective
9.5 Anti-allergic
9.6 Cholinergic
9.7 Others
10 Asia-pacific Dry Eye Syndrome Market, By Dose
10.1 Overview
10.2 Multi Dose
10.3 Unit Dose
11 Asia-pacific Dry Eye Syndrome Market, By Medication Type
11.1 Overview
11.2 Prescription (Rx) Drugs
11.3 Over The Counter (Otc) Drugs
12 Asia-pacific Dry Eye Syndrome Market, By Container Type
12.1 Overview
12.2 Unit Dose Vials
12.3 Bottles
12.4 Tubes
13 Asia-pacific Dry Eye Syndrome Market, By Packaging Type
13.1 Overview
13.2 Plastic
13.3 Glass
13.4 Aluminium
14 Asia-pacific Dry Eye Syndrome Market, By Type
14.1 Overview
14.2 Generic Drug
14.3 Branded
14.3.1 Restasis
14.3.2 Xiidra
14.3.3 Refresh
14.3.4 Systane
14.3.5 Tears Naturale
14.3.6 Ikervis
14.3.7 Diquas
14.3.8 Others
15 Asia-pacific Dry Eye Syndrome Market, By End User
15.1 Overview
15.2 Home Healthcare
15.3 Hospitals
15.4 Clinics
15.5 Others
16 Asia-pacific Dry Eye Syndrome Market, By Distribution Channel
16.1 Overview
16.2 Hospital Pharmacies
16.3 Retail Pharmacies
16.4 Online Pharmacies
16.5 Others
17 Asia-pacific Dry Eye Syndrome Market By Geography
17.1 Asia-pacific
17.1.1 Japan
17.1.2 China
17.1.3 India
17.1.4 South Korea
17.1.5 Australia
17.1.6 Singapore
17.1.7 Thailand
17.1.8 Malaysia
17.1.9 Indonesia
17.1.10 Philippines
17.1.11 Rest Of Apac
18 Asia-pacific Dry Eye Syndrome Market, Company Landscape
18.1 Company Share Analysis: Asia-pacific
19 Swot Analysis
19.1 Data Bridge Market Research Analysis-
20 Company Profile
20.1 Allergan
20.1.1 Company Snapshot
20.1.2 Revenue Analysis
20.1.3 Company Share Analysis
20.1.4 Geographical Presence
20.1.5 Product Portfolio
20.1.6 Recent Developments
20.2 Novartis Ag
20.2.1 Company Overview
20.2.2 Revenue Analysis
20.2.3 Company Share Analysis
20.2.4 Geographical Presence
20.2.5 Product Portfolio
20.2.6 Recent Development
20.3 Bausch & Lomb Incorporated.
20.3.1 Company Snapshot
20.3.2 Revenue Analysis
20.3.3 Company Share Analysis
20.3.4 Geographical Presence
20.3.5 Product Portfolio
20.3.6 Recent Development
20.4 Santen Pharmaceutical Co., Ltd.
20.4.1 Company Overview
20.4.2 Revenue Analysis
20.4.3 Company Share Analysis
20.4.4 Geographical Presence
20.4.5 Product Portfolio
20.4.6 Recent Development
20.5 Johnson & Johnson Services, Inc.
20.5.1 Company Snapshot
20.5.2 Revenue Analysis
20.5.3 Company Share Analysis
20.5.4 Geographical Presence
20.5.5 Product Portfolio
20.5.6 Recent Developments
20.6 Akorn, Incorporated
20.6.1 Company Overview
20.6.2 Revenue Analysis
20.6.3 Geographical Presence
20.6.4 Product Portfolio
20.6.5 Recent Development
20.7 Alcon Inc
20.7.1 Company Snapshot
20.7.2 Revenue Analysis
20.7.3 Geographical Presence
20.7.4 Product Portfolio
20.7.5 Recent Development
20.8 Alembic Pharmaceuticals Limited
20.8.1 Company Snapshot
20.8.2 Revenue Analysis
20.8.3 Geographical Presence
20.8.4 Product Portfolio
20.8.5 Recent Developments
20.9 Cardinal Health
20.9.1 Company Snapshot
20.9.2 Revenue Analysis
20.9.3 Geographical Presence
20.9.4 Product Portfolio
20.9.5 Recent Developments
20.10 Cipla Inc
20.10.1 Company Snapshot
20.10.2 Revenue Analysis
20.10.3 Geographical Presence
20.10.4 Product Portfolio
20.10.5 Recent Developments
20.11 Horus Pharma
20.11.1 Company Overview
20.11.2 Geographical Presence
20.11.3 Product Portfolio
20.11.4 Recent Development
20.12 Hubrx
20.12.1 Company Snapshot
20.12.2 Product Portfolio
20.12.3 Recent Developments
20.13 Novaliq Gmbh
20.13.1 Company Overview
20.13.2 Geographical Presence
20.13.3 Product Portfolio
20.13.4 Recent Development
20.14 Perrigo Company Plc
20.14.1 Company Snapshot
20.14.2 Revenue Analysis
20.14.3 Geographical Presence
20.14.4 Product Portfolio
20.14.5 Recent Development
20.15 Prestige Consumer Healthcare, Inc.
20.15.1 Company Snapshot
20.15.2 Revenue Analysis
20.15.3 Product Portfolio
20.15.4 Recent Developments
20.16 Rohto Pharmaceutical Co., Ltd.
20.16.1 Company Snapshot
20.16.2 Revenue Analysis
20.16.3 Geographical Presence
20.16.4 Product Portfolio
20.16.5 Recent Development
20.17 Senju Pharmaceutical Co. Ltd.
20.17.1 Company Overview
20.17.2 Revenue Analysis
20.17.3 Geographical Presence
20.17.4 Product Portfolio
20.17.5 Recent Development
20.18 Sun Pharmaceutical Industries Ltd.
20.18.1 Company Snapshot
20.18.2 Revenue Analysis
20.18.3 Geographical Presence
20.18.4 Product Portfolio
20.19 Teva Pharmaceutical Industries Ltd.
20.19.1 Company Snapshot
20.19.2 Revenue Analysis
20.19.3 Geographical Presence
20.19.4 Product Portfolio
20.19.5 Recent Development
20.19.6 Recent Developments
20.20 Visufarma
20.20.1 Company Overview
20.20.2 Geographical Presence
20.20.3 Product Portfolio
20.20.4 Recent Developments
21 References
22 Questionnaire
23 Related Reports

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook